Dr. Xu is director of regulatory affairs in companion diagnostics at Agilent. She has extensive experience in regulatory submissions, handling drug-diagnostic co-development interactions, and providing regulatory strategies in large collaboration projects with major pharma companies. She has broad-based knowledge encompassing IVD product development, design control, clinical trials, regulatory submissions, and risk management to properly guide successful product launches and updates. 

Dr. Xu received her medical degree from Capital Medical University in Beijing and her Ph.D. in biomedical science from the University of California – Riverside.